The short version of Melanocortin receptor fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Published research has focused mainly on neurological and cognitive endpoints in animal models, with proposed mechanisms involving brain-derived neurotrophic factor and related signalling pathways. A substantial share of the human data originates from a limited number of research groups, and independent replication in other countries remains sparse. Regulatory status reflects that distribution: the peptide is registered as a medicine in Russia and appears in some neighbouring markets, while elsewhere it is handled as a research chemical without approved therapeutic labelling. Questions about dose-response relationships, long-term effects, and comparability across studies are still open.
Lyophilised powder is normally kept at -20 °C in a desiccated container, with some suppliers recommending -80 °C for long-term archival storage. Repeated freeze-thaw cycles are the most common cause of avoidable loss, so aliquoting before freezing reduces variability between working sessions. Dissolved peptide is far less stable than the dry solid and is usually prepared fresh or held briefly at 4 °C. Aqueous solutions support both hydrolysis of the backbone and oxidation of the N-terminal methionine, and these two routes dominate degradation under ordinary laboratory conditions.
Identity and purity are confirmed with reversed-phase high-performance liquid chromatography, typically monitored at 214 nanometres where the peptide bond absorbs. Mass spectrometry, either electrospray or MALDI-TOF, verifies molecular mass against the theoretical value and detects truncation or adduct formation. Amino acid analysis and peptide mapping provide additional confirmation when required. The most frequently reported impurities are deletion sequences from incomplete coupling, methionine sulfoxide from oxidation, and dimeric species formed through non-covalent aggregation. Impurity profiles depend strongly on the synthesis and purification route chosen by the producer.
Scientific literature on semax is unevenly distributed. A substantial share of published work originates from a small number of laboratories in Russia, while independent replication elsewhere is limited. Human data consist mostly of small trials with short follow-up, and several reported outcomes rely on subjective rating scales. Questions about how much intact peptide reaches the central nervous system after nasal administration, and how long it persists there, are still unresolved. The compound is best described as an active research subject rather than a settled pharmacological agent.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It was derived from the ACTH(4-10) fragment, a short segment of adrenocorticotropic hormone that lacks the hormonal activity associated with the full-length peptide. Researchers at the Institute of Molecular Genetics in Moscow developed the compound during the 1980s. It has been registered as a pharmaceutical product in Russia and several neighbouring countries, where it is supplied as a nasal solution, and it is also sold internationally as a research chemical.
The proposed mechanism centres on neurotrophic signalling rather than direct receptor activation. Semax is reported to increase expression of brain-derived neurotrophic factor and nerve growth factor in several brain regions, and to shift the balance between excitatory and inhibitory neurotransmitter systems. Interaction with melanocortin receptors has been suggested because of the parent ACTH fragment. Many of these findings come from rodent studies, and the extent to which they translate to human physiology remains an open question.
| Property | Value | Notes |
|---|---|---|
| Purity assay | RP-HPLC, UV 214 nm | Typical research grade 95 percent or higher |
| Mass confirmation | ESI-MS or MALDI-TOF | Compared with theoretical value |
| Main degradation route | Methionine oxidation | Sulfoxide formation in solution |
| Powder storage | -20 °C, desiccated | Amber vial, minimal headspace |
| Working solution | Sterile water or saline | Prepare fresh; avoid repeated thawing |
Verification of a supplied batch generally combines a certificate of analysis with independent testing, because certificates are self-reported documents. A typical package includes a chromatographic trace, a mass spectrum, and a stated water or counter-ion content. Batch-to-batch consistency matters more than a single purity figure when results are compared across experiments. No single mandatory standard governs research-grade peptide release, so laboratories are expected to define their own acceptance criteria. Residual trifluoroacetate from purification is a frequently overlooked counter-ion.
Lyophilized material is chemically stable for extended periods when kept dry, cold, and protected from light. The powder is hygroscopic, so vials should be warmed to room temperature before opening to reduce condensation on the contents. Once dissolved, the peptide is far less stable because peptide bonds are susceptible to hydrolysis and the methionine residue can oxidize. Solutions are typically aliquoted and held at 2-8 °C for short intervals or frozen for longer ones, and repeated freeze-thaw cycles should be avoided.
Routine characterization relies on reversed-phase high-performance liquid chromatography to establish purity and on mass spectrometry to confirm molecular identity. Electrospray ionization and matrix-assisted laser desorption ionization are both used for mass verification. Amino acid analysis and peptide mapping can detect sequence errors. Common impurities include truncated sequences, methionine sulfoxide formed by oxidation, and deamidated products. Chromatograms are usually recorded near 214 nm, where the peptide backbone absorbs, and purity is reported as the percentage area of the principal peak.
Regulatory status varies sharply by country. Semax is registered for medical use in Russia, where it appears in formularies as a nasal solution, and it also holds registration in a small number of neighbouring states. It has no approval from the United States Food and Drug Administration or the European Medicines Agency, and it is not a scheduled controlled substance in most jurisdictions. Elsewhere it circulates mainly as laboratory material, so purity documentation comes from suppliers rather than from a national pharmacopoeia.
Semax is a synthetic peptide created in the Soviet Union during the early 1980s by researchers working in Moscow. It was built from the short adrenocorticotropic hormone fragment known as ACTH(4-10), and the chain was then extended with three additional amino acids. The resulting molecule was named semax and entered clinical use in Russia in 1994. It is generally described as a nootropic and neuroprotective agent rather than as a hormone analogue.
The parent fragment ACTH(4-10) carries the sequence Met-Glu-His-Phe-Arg-Trp-Gly. Semax replaces the arginine and tryptophan positions with a proline-glycine-proline tail, giving Met-Glu-His-Phe-Pro-Gly-Pro. That change removes residues associated with adrenal stimulation, so the peptide does not drive cortisol release the way full ACTH does. This distinction shapes how the compound is grouped in the literature, where it sits with neuropeptides and peptide neuromodulators rather than with corticosteroids.
Published research covers ischemic stroke, traumatic brain injury, cognitive impairment, optic nerve conditions and attention-related measures. Much of the human evidence comes from small trials conducted in one country, which limits how far the results generalize. Animal models supply the larger share of the data, and effects seen in rodents do not transfer automatically to people. Reviews have noted that methodological reporting is often incomplete, making it difficult to pool results or compare treatment schedules across studies.
Pharmacokinetic accounts emphasize rapid breakdown. After intravenous dosing the intact peptide disappears from blood within minutes, and nasal delivery produces low but measurable concentrations. Metabolites rather than the parent molecule may account for part of the observed activity, although the relative contribution is unresolved. Dosing in the literature varies widely and no optimal schedule has been agreed. These gaps are regularly cited as a reason the findings have not produced broad clinical adoption beyond the original research setting.
Proposed mechanisms center on neurotrophic signaling rather than on classical melanocortin receptor activation. Rodent experiments have reported shifts in the expression of brain-derived neurotrophic factor and nerve growth factor after administration, together with changes in the associated receptor systems. Several authors argue that the peptide acts largely through its degradation products and their interaction with peptidergic pathways, but this remains a hypothesis rather than a settled finding. No single molecular target has been identified in a way that the field broadly accepts.
Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. It was developed as a fragment analog of adrenocorticotropic hormone, modeled specifically on the ACTH(4-10) region. The first four residues reproduce that fragment, while a Pro-Gly-Pro tripeptide is appended at the C-terminus. Work on the compound originated in Russia, where it entered clinical use as an intranasal preparation. Its sequence places it among short regulatory peptides studied for effects on the central nervous system rather than on the adrenal axis.
The C-terminal Pro-Gly-Pro extension is not incidental. Proline-rich tails are known to resist several common peptidases, and the published literature attributes the longer half-life of Semax, relative to unmodified ACTH fragments, to this feature. The modification also removes the melanocyte-stimulating and corticosteroidogenic activity that characterizes longer ACTH-derived sequences. Because the molecule is small and hydrophilic, it is typically formulated as an aqueous solution for intranasal or parenteral delivery. Acetylation or amidation at the termini appears in closely related research peptides and shifts the mass by a fixed increment.
White sharks are estimated to swim 2.88–4.86 km/h (1.79–3.02 mph) but can sprint up to 24.12 km/h (14.99 mph). One individual was recorded cruising at a sustained speed of 4.7 km/h (2.9 mph) while migrating, which is fast for a shark and more similar to fast-swimming tuna. White sharks display various surface behaviors. These include spyhopping (poking head out of the surface) to observe an object above the water, as well as 'repetitive aerial gaping' where a spyhopping shark repeatedly gapes its mouth while belly-up, possibly as a sign of frustration after missing a bait. How they sleep is not well understood. At night, one individual was recorded swimming slowly in one direction along a current with its mouth open. The white shark is generally considered to be a solitary species, though aggregations do occur. A 2016 study of sharks around Mossel Bay, South Africa, concluded that white shark associations are generally random with few social interactions. By contrast, a 2019 study found that sharks around Neptune Islands gathered in non-random aggregations. Similarly, a 2022 study of white sharks at Guadalupe Island suggested that individuals may associate so that they can learn from others where to find prey or carcasses to scavenge. White shark aggregations can consist of individuals of a specific age and sex. At Neptune Islands, sightings of subadult females peak during April and May, subadult males in February and again in September, adult females in June, and adult males in September.
0.063 in or 1.6 mm 0.058 in or 1.5 mm 0.050 in or 1.3 mm 0.043 in or 1.1 mm The end of the saw power head has two oil holes, one on each side. These holes must match with the outlet of the oil pump. The pump sends the oil through the hole in the lower part of the gauge. Saw bar producers provide a large variety of bars matching different saws. Grease is pumped through a hole at the bar nose, typically each tank filling to keep the nose sprocket well lubricated. One or two bolts from the saw run through a guide slot. The clutch cover is put on top of the bar and it is secured through these bolts. The number of bolts is determined by the size of the saw. Different bar types are available:
Hemp juice is produced in a patented industrial procedure directly following harvest whereby the leafy upper part of the plant, including the flower heads, are being cold-pressed after harvest. These parts of the hemp plant have been entirely neglected so far in industrial hemp fabric production. Hence, through the procedure of pressing juice, a previously neglected highly valuable part of the plant is now being used for human consumption. All active ingredients remain fully intact without drying the hemp. The juice does not compete with the production of fibers and shives instead both add up to double revenue of the farmer. The average yield of hemp juice is approximately 3 tons per hectare. This newly developed production procedure allows for a significantly higher financial efficiency as well as sustainability in the cultivation of drug-free industrial hemp. Furthermore, the cold-pressing procedure preserves all of the plant-based active ingredients. There are two common harvesting procedures: "Cutting" the upper parts of the hemp plant or "stripping" the leaves off the uppermost part of the hemp plant. Both these procedures result in varying quantities of cannabinoids in the hemp juice. Consequently, the harvesting procedure in itself already influences the quality of the resulting hemp juice. If one only uses the uppermost, leafy part of the hemp plant for hemp juice production, the remaining part of the hemp plant can still be used for the industrial production of its fibers or any other industrial uses.
Researchers at the MD Anderson Cancer Center activated the telomerase reverse transcriptase gene, which declines with age, in mice and found that it both lengthened telomeres in cells and that signs of aging in cells that had not synthesized telomeres were also ameliorated suggesting that telomerase reverse transcriptase is responsible for regulating genes involved in aging independent of its role in building telomeres. Researchers at the Institute for Research in Biomedicine demonstrated that senescent cells release mt-dsRNA into the cytosol driving the SASP via RIGI/MDA5/MAVS/MFN1, and in turn are hypersensitive to mt-dsRNA-driven inflammation due to reduced levels of PNPT1/ADAR1. Moreover, senescent cells within fibrotic and aged tissues also present increased dsRNA foci, and inhibition of mitochondrial RNA polymerase reduces systemic inflammation associated to senescence. A study at Tufts Medical Center identified more than 300 unique metabolic markers associated with aging, extreme longevity, and mortality. Researchers at Stanford University reported reversing signs of Alzheimer's disease in the brains of mice by removing the enzyme IDO1, which changed the behavior of astrocytes, as IDO1 levels rise in the brain and astrocytes stop performing their function when Alzheimer's appears. The results were repeated with human astrocytes and neurons from Alzheimer's patients.
== Forensic detection == Worldwide, certain traditional Chinese medicines contain wild bear bile, banned under CITES legislation. Dip sticks, similar to common pregnancy tests, have been developed to detect the presence of bear albumin in traditional medicine products, indicating that bear bile had been used in their creation.
Sources: en.wikipedia.org
Cure T1D by restoring the body’s ability to produce insulin and stopping T1D before it occurs or providing insulin independence through replacement with insulin-producing cells. Improve lives by minimizing the effects of T1D as much as possible until new T1D resources, technologies, and therapies are discovered. Breakthrough T1D prioritizes four strategic research areas; autoimmune therapies, cell therapies, prevention of complications, and glucose control.
Historically, when Cossack men fought in permanent wars far from home, women took over the role of family leaders. Women were also called upon to physically defend their villages and towns from enemy attacks. In some cases, they raided and disarmed neighboring villages composed of other ethnic groups. Leo Tolstoy described such Cossack female chauvinism in his novel, The Cossacks. Relations between the sexes within the stanitsas were relatively egalitarian. The American historian Thomas Barrett wrote "The history of Cossack women complicates general notions of patriarchy within Russian society". When the Malorossian Cossack regiments were disbanded, those Cossacks who were not promoted to nobility, or did not join other estates, were united into a civil Cossack estate. Sergei Korolev's mother was the daughter of a leader of the civil estate of the Zaporozhian Sich.
Liver chestnut or dark chestnut are not a separate genetic color, but a descriptive term. The genetic controls for the depth of shade are not presently understood. Liver chestnuts are a very dark-reddish brown. Liver chestnuts are included in the term "dark chestnut." The darkest chestnuts, particularly common in the Morgan horse, may be indistinguishable from true black without very careful inspection. Often confusingly called "black chestnuts", they may be identified by small amounts of reddish hair on the lower legs, mane and tail, or by DNA or pedigree testing. Recently, it has been suggested that the trait or traits that produce certain darker shades of chestnut and bay, referred to as "sooty" coloration follow a recessive mode of inheritance.
Gindilis, there are two criteria for a signal to be called artificial: one related to the artificial nature of the source and the other related to a particular radiation, intentionally designed to ensure communication and facilitate detection. Only Type II or III civilizations can communicate using isotropic transmissions that allow omnidirectional reception. In a 1 MHz band (which requires about 1024 watts), detection of signals from a Type II civilization is possible up to 1,000 light-years away, while signals from a Type III civilization are detectable virtually throughout the observable Universe. However, building an omnidirectional transmitter powerful enough to transmit over a range of 1,000 light years would take several million years. According to V.S. Troitsky, the energy required and the limitations in its production would be two obstacles to completing this project in a reasonable time. For Zoltan Galántai, we would not be able to distinguish between an intelligent extraterrestrial signal and a signal of natural origin. Therefore, he does not believe that Type II, III or even IV civilizations can be detected. Even if humanity reaches Type IV, it will not be able to detect another supercivilization of a similar level, and we will consider their changes in the universe to be the result of natural causes. Thus, there may be many Type IV civilizations in the universe, but none of them will be able to detect the others. Moreover, the dimensions of the universe make these supercivilizations like islands far from the others, which Dyson defines as a "Carroll Universe".
Butyrfentanyl or butyrylfentanyl is a potent short-acting synthetic opioid analgesic drug. It is an analog of fentanyl with around one quarter of its potency. One of the first mentions of this drug can be found in document written by The College on Problem of Drug Dependence, where it is mentioned as N-butyramide fentanyl analog. This document also states that the article describing its clinical effects (analgesic studies, μ-, δ-, κ-opioid receptor binding, and in vitro measures of drug efficacy, antinociceptive, and narcotic properties) was published in 1987. It is an agonist for the μ-opioid receptors. Butyrfentanyl has no current legitimate clinical applications; however, it is being sold as a designer drug. Side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea, and potentially serious respiratory depression which can be life-threatening. Fentanyl analogs have killed hundreds of people throughout Europe and the former Soviet republics since the most recent resurgence in use began in Estonia in the early 2000s, and novel derivatives continue to appear.
Sources: en.wikipedia.org
Reversed-phase HPLC gives the main purity figure, most often with UV detection near 214 nanometres. Mass spectrometry then confirms the molecular mass. Together the two methods distinguish a correct sequence from a closely related impurity.
The main chemical risks are methionine oxidation and backbone hydrolysis in solution. Moisture and repeated temperature cycling accelerate both processes. Dry powder held cold and desiccated is considerably more stable than any reconstituted preparation.
It holds a medicine registration in Russia, where it has been used clinically for decades. In most other countries it is treated as a research chemical. That split explains the uneven distribution of clinical literature.
Semax is based on the ACTH(4-10) fragment, a seven-amino-acid segment of adrenocorticotropic hormone. The synthetic peptide retains the core sequence while removing regions associated with endocrine activity. This modification is intended to isolate effects on the nervous system.